Moreover, SF2523, a pan-PI3K and dual BRD4 inhibitor, inhibited the growth of lung, melanoma, and colorectal cancers in syngeneic models, which was associated with reduced infiltration of MDSCs and restoration of CD8+ T cell function [139]. Here, PIK3CD is linked to melanoma.